Christopher CRO Foot B.A., M.Ed.
About Christopher CRO Foot B.A., M.Ed.
Christopher CRO Foot is the National Director Healthcare at CIBC, with extensive experience in business development and corporate partnerships within the healthcare sector.
Company: CIBC
Christopher CRO Foot serves as the National Director Healthcare at CIBC. He has been in this role since 2021, during which he oversees the healthcare division. CIBC is one of the leading banks in Canada, and Christopher's role involves significant responsibilities related to financial services within the healthcare sector.
Previous Roles at BMO Financial Group
Christopher CRO Foot was the Director Of Business Development - Healthcare Finance at BMO Financial Group from 2018 to 2021. In this role, he focused on expanding business development efforts within the healthcare sector, contributing to the growth and strategic positioning of BMO's healthcare finance division.
Previous Roles at McKesson Canada
Christopher CRO Foot worked at McKesson Canada as the Director Of Business Development : Pharmacy Banners from 2014 to 2017. His role involved spearheading business development initiatives for pharmacy banners, enhancing McKesson's market position in Ontario, Canada.
Educational Background
Christopher CRO Foot has a diverse educational background. He studied at Wilfrid Laurier University, earning a B.A. in Biology and Physical Education from 1988 to 1993. He further pursued a M.Ed. in Pedagogy and Postmodernism at York University from 1997 to 1999. Additionally, he studied at Canisius College and the University of Guelph in various disciplines but did not complete M.Sc Ed and Ph.D programs respectively.
Expertise in Healthcare and Business Development
Christopher CRO Foot has extensive experience in business development and corporate partnerships within the healthcare sector. His career includes roles such as Executive Director at Xynnolex and Director of Business Development at McKesson Canada and other healthcare companies. His contributions have significantly impacted market development and corporate partnerships in the healthcare industry.